Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Silvaco Reports Third Quarter 2024 Financial Results
-
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Synchronoss Technologies Reports Third Quarter 2024 Results
-
Datadog to Present at Upcoming Investor Conferences
-
Ormat Technologies Announces Major EPC Contract With Contact Energy for 101MW Geothermal Plant in New Zealand
-
Rumble Reports Third Quarter 2024 Results
-
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates
-
Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research
-
Iridex Reports Third Quarter 2024 Financial Results
-
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
-
PLBY Group Reports Third Quarter 2024 Financial Results
-
TeraWulf Reports Third Quarter 2024 Financial Results
-
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
-
Interparfums, Inc. Announces Initial 2025 Guidance
-
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
-
HF Foods Reports Third Quarter 2024 Financial Results
-
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
-
iBio Reports Fiscal First Quarter 2025 Financial Results
-
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
-
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
-
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Nuvation Bio to Present at the Jefferies London Healthcare Conference
-
Eloxx Pharmaceuticals Announces Key Corporate Accomplishments
-
ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
-
AI Solutions Startup Secures $15m in Fundraising Round
-
QIAGEN collaborates with McGill University to advance microbiome research
-
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Build-A-Bear Workshop, Inc. Declares Quarterly Cash Dividend
-
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
OrthoPediatrics Corp. to Participate in Upcoming Conferences
-
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
-
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Westrock Coffee Company to Participate in the Stephens Annual Investment Conference
-
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference
-
DoorDash CFO to Participate in Fireside Chat at Upcoming Investor Conference
-
KBRA Assigns Ratings to Various Sales Tax Securitization Corporation Sales Tax Securitization Bonds (AAA) and Second Lien Sales Tax Securitization Bonds (AA+); Affirms Ratings for Outstanding Bonds an
-
Eaton selected by the United States Air Force Research Laboratory to design innovative aerial refueling system
-
Amdocs Limited Reports Fourth Quarter & Fiscal Year 2024 Results
-
Paul Mueller Company Declares Quarterly Cash Dividend
-
Viant Technology Announces Acquisition of IRIS.TV
-
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
-
Progyny, Inc. Announces Third Quarter 2024 Results
-
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Monroe Capital Corporation BDC Announces Third Quarter 2024 Results
-
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
-
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

